News Clearmind to collaborate with Johns Hopkins University to study promising psychedelic treatment for alcohol use disorder Johns Hopkins University School of Medicine is the second U.S. clinical site to join Clearmind's trial, following Yale School of Medicine's psychiatry department Natalia Buendia CalvilloSeptember 6, 2023
Cannabis Aurora Cannabis partners with Brazilian firm to expand CBD portfolio The CBD oil is produced at Aurora's production facility in Uruguay Natalia Buendia CalvilloSeptember 6, 2023
Copper Copper mining market to reach $11.17B by 2030: Fortune Business Insights Latin America dominated the copper mining market share, primarily due to the extensive presence of copper mines Natalia Buendia CalvilloSeptember 5, 2023
Mining SightPower to develop AI-based automated mine shaft inspection system The core of this technology involves a hardware device equipped with a laser scanner and a high-resolution camera Natalia Buendia CalvilloSeptember 5, 2023
Mining BQE Water partners with Yukon Govt for Minto Mine water management The current priority at the mine is on maintaining the pits that store contaminated water Natalia Buendia CalvilloSeptember 1, 2023
Alternative Energy Newfoundland and Labrador greenlights World Energy GH2’s pioneering wind-to-green-hydrogen initiative The company is now initiating a dialogue and engagement process with communities located near the areas earmarked for future expansion Natalia Buendia CalvilloSeptember 1, 2023
Psychedelics Otsuka Pharmaceutical seals $80M all-cash deal to acquire Mindset Pharma Mindset shareholders will receive $0.75 in cash for each share, representing a premium based on various trading metrics Natalia Buendia CalvilloAugust 31, 2023
Cannabis Cannabis soothes anxiety and depression in patients with fibromyalgia: MediPharm Labs study It found that 75 per cent of patients saw a significant decrease in their self-reported illness severity Natalia Buendia CalvilloAugust 31, 2023
Cannabis U.S. health department urges DEA to re-classify cannabis as a less dangerous substance Cannabis is currently scheduled under Schedule I which are deemed drugs with a high risk of abuse such as heroin Natalia Buendia CalvilloAugust 31, 2023
News Silo Wellness to acquire NUGL/Kaya Group in a $43.3M deal Silo Wellness will acquire all of NUGL's issued and outstanding shares in exchange for 2 million shares from its treasury Natalia Buendia CalvilloAugust 30, 2023